More people who have no previous diagnosed neurological conditions are asking for neuroenhancements or so-called "smart drugs." Given the drug side effects, what ethical responsibilities fall on prescribers to help screen and prevent misuse of medication? Furthermore, is neuroenhancement prescribing skewing the number of ADHD and or other diagnoses? "The Pediatric neuroenhancment: Ethical, legal, social, and neurodevelopmental implications" article helps answer these questions.
Link to article